Trial Profile
A pilot study to evaluate the effect of concomitant use of Emtricitabine/rilpivirine/tenofovir-disoproxil-fumarate and atorvastatin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2017
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 02 Jan 2017 New trial record